Volume 2
Archive

Contents

Diagnosis & Evaluation

Yael Mardor, Roberto Spiegelmann, Yiftach Roth, Arie Orenstein, Stephan E. Maier, Ouzi Nissim, Zvi Ram, Jacob Baram, Thomas Tichler, Raphael Pfeffer
Pre-treatment prediction of brain tumor response to radiation therapy using high diffusion-weighted MRI
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 2547 

A A. Tzika, Loukas G. Astrakas, David Zurakowski, Maria K. Zarifi, Tina P. Young, Liliana Goumnerova, Douglas C. Anthony, Mark Kieran, Nancy J. Tarbell, Peter M. Black
Predicting progression in children with pediatric brain tumors using magnetic resonance neuroimaging
Proceedings of the AACR, Volume 44, 1st ed., March 2003, Abstract No. 3411

Epidemiology & Risk Factors

Preetha Rajaraman, Anneclaire De Roos, Patricia Stewart, Martha Linet, Peter Inskip
Occupational risk factors for meningiomas and acoustic neuromas in the United States
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. R6391

Etiology & Pathogenesis

Emmanuelle Di Tomaso, Edward Brown, Yotaro Izumi, Rakesh K. Jain
A novel, orthotopic model of glioblastoma growth and invasion for intravital microscopy
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 2956

Michael A. Grotzer, Carmen Meier, Tarek Shalaby, Doris Lang
Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma
Proceedings of the AACR, Volume 44, 1st ed., March 2003, Abstract No. 2098

Mladen Golubic, Naren Nathoo, Richard A. Prayson, Linda Vargo, Judy Bondar, Susana Arrigain, Gene H. Barnett
Increased expression of 5-lipoxygenase in glioblastoma multiforme
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. R4983 

Integrative Medicine

Overall Management

Treatment

Azita E. Gilardi, H. Rodney Withers
Somnolence induced by radiation therapy of brain tumor
Proceedings of the AACR, Volume 44, 1st ed., March 2003, Abstract No. 2548 

Susan E. Jones-Bolin, Hugh Zhao, Kathryn Hunter, Bruce Ruggeri
Effects of chronic oral administration of the pan VEGF-R kinase inhibitor, CEP-7055, alone and in combination with temozolomide (TMZ), on primary tumor growth, neurological dysfunction, and survival in an orthotopic model of human glioblastoma in nude mice
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 61 

Huan Ren, Alf Giese, Tingchang Chou, Steven Pelech, Nikolai Rainov
Biological activity of a novel tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class, Imatinib (STI571, Gleevec), on human glioblastoma cells
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. R3776

Lucio Tentori, Carlo Leonetti, Marco Scarsella, Giulia d'Amati, Weizheng Xu, Vincent Kalish, Jie Zhang, Gabriella Zupi, Grazia Graziani
Systemic administration of the PARP inhibitor GPI 15427 increases the anti-tumor activity of temozolomide in melanoma, glioma and lymphoma preclinical models in vivo
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 5466 

Arabel Vollmann, Hans-Peter Vornlocher, Anke Geick, Thilo Spruss, Rainer Apfel, Gerhard Giegerich, Ulrich Bogdahn
RNAi mediated effective inhibition of EGFP and EGF-R gene expression in malignant glioma
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 737 

Yinglin Wang, Linda M. Liau, Timothy F. Cloughesy, Paul S. Mischel
p53 status determines the cell fate of glioblastoma cells in response to SN-38
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 2683 

Mateo Ziu, Nils O. Schmidt, Yanping Sun, Mitchell Albert, Peter M. Black, Rona S. Carroll
Local delivery of anti-angiogenic compounds to human orthotopic glioblastoma xenografts improves treatment efficacy and survival
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 6464